BIOMAT Database Logo BIOMAT Database Logo

Hormone replacement therapy in breast cancer. 1993

P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
[Breast cancer and hormone replacement therapy].
April 1999, Schweizerische medizinische Wochenschrift,
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Breast cancer and hormone replacement therapy.
October 1997, Lancet (London, England),
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Hormone-replacement therapy and breast cancer.
May 2002, The Lancet. Oncology,
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Hormone replacement therapy and breast cancer.
November 1997, Lancet (London, England),
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Breast cancer and hormone-replacement therapy.
November 1995, The New England journal of medicine,
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Breast cancer and hormone-replacement therapy.
November 1995, The New England journal of medicine,
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Breast cancer and hormone-replacement therapy.
November 1995, The New England journal of medicine,
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Breast cancer and hormone-replacement therapy.
November 1995, The New England journal of medicine,
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Hormone replacement therapy and breast cancer.
November 1997, Lancet (London, England),
P J DiSaia, and F Odicino, and E A Grosen, and B Cowan, and S Pecorelli, and A G Wile
Breast cancer and hormone-replacement therapy.
November 1995, The New England journal of medicine,
Copied contents to your clipboard!